However, the absence or downregulation of HLA class Ia can promote the expression of new tumor peptides presented by HLA-E, therefore activating unconventional CD8+ T cells through HLA-E–peptide–specific recognition by TCRs. This evidence concerns the gene HLA-E and neoplasm.